Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Detection Platform Receives Homogenous Time-Resolved Fluorescence Certification

By Biotechdaily staff writers
Posted on 19 Feb 2008
A unique, modular detection platform has been awarded homogenous time-resolved fluorescence (HTRF) certification. More...
This verifies that the platform meets or exceeds performance criteria for HTRF assays.

A new HTRF detection cartridge is now available for the modular Paradigm platform bringing its growing total selection to 10. These detection cartridges can be interchanged in less than five minutes to meet different assay needs. Paradigm is a user-upgradeable and configurable multimode reader. It is ideal for labs with multiple users and applications. The high-throughput detector reads on the fly, in formats from 6 to 1,536 wells.

Cisbio's (Saclay, France) HTRF detection cartridge was added to Beckman Coulter's (Fullerton, CA, USA) modular platform, Paradigm. The HTRF technology is incorporated into a growing selection of assays and reagents for screening and drug discovery. These assays produce good results and are easily miniaturized and automated.

Jim Barry, marketing manager for Beckman Coulter explained, "Detection modes are difficult and costly to add to other multimode detectors once the systems are installed. Our detection cartridge system maximizes the users' return on investment and our instruments and automation platforms are already well established in drug discovery and screening labs, where the use of TR-FRET assays, specifically HTRF [is] growing.” TR-FRET unites time-resolved fluorescence (TRF) and fluorescence resonance energy transfer (FRET) principles.

Cisbio is a global developer of products and technologies used in nuclear medicine, in- vitro diagnostics, and assay development for drug screening procedures. The company pioneered the field of homogenous fluorescence methodologies via its proprietary technology, HTRF, a sensitive, robust technology for the detection of molecular interactions.

Beckman Coulter Inc. develops, manufactures, and markets products that simplify, automate, and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world supplying critical information for improving patient health and reducing the cost-of-care.


Related Links:
Cisbio
Beckman Coulter

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Serological Pipet Controller
PIPETBOY GENIUS
New
Urine Chemistry Control
Dropper Urine Chemistry Control
New
Rapid Test Reader
DIA5000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The ONC IN-CYT platform leverages cross indication biomarker cyto-signatures (Photo courtesy of OraLiva)

AI-Powered Cytology Tool Detects Early Signs of Oral Cancer

Each year, 54,000 Americans are diagnosed with oral cancer, yet only 28% of cases are identified at an early stage, when the five-year survival rate exceeds 85%. Most diagnoses occur in later stages, when... Read more

Hematology

view channel
Image: The microfluidic device for passive separation of platelet-rich plasma from whole blood (Photo courtesy of University of the Basque Country)

Portable and Disposable Device Obtains Platelet-Rich Plasma Without Complex Equipment

Platelet-rich plasma (PRP) plays a crucial role in regenerative medicine due to its ability to accelerate healing and repair tissue. However, obtaining PRP traditionally requires expensive centrifugation... Read more

Immunology

view channel
Image: PD-1 protein blockade is the standard treatment for advanced melanoma among the different types of immunotherapy (Photo courtesy of 123RF)

Precision Tool Predicts Immunotherapy Treatment Failure in Melanoma Patients

Melanoma, though accounting for only about 4% of skin tumors, is the deadliest form of skin cancer due to its high potential to metastasize. While immunotherapy, especially PD-1 protein blockade, has revolutionized... Read more

Pathology

view channel
Image: Researchers have developed a novel method to analyze tumor growth rates (Photo courtesy of Adobe Stock)

Novel Method To Analyze Tumor Growth Rates Helps Tracks Progression Between Diagnosis and Surgery

Patients diagnosed with breast cancer often worry about how quickly their tumors grow while they wait for surgery, and whether delays in treatment might allow the disease to spread beyond the point of cure.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.